Intelligence Platform

Patents

Browse 54 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12298315

Systems and methods to identify and treat subjects at risk for obstetrical complications

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12173306

Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorde

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12054519

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotype

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11999747

Furoquinolinediones as inhibitors of TDP2

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11878004

Method for inhibiting Zika virus infection

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11802283

Oligonucleotide analogues targeting human LMNA

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11654147

ALK2 inhibitors and methods for inhibiting BMP signaling

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11542261

Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11434268

Vascular endothelial growth factor antagonists

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11371024

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11254667

Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11136372

ApoC-II mimetic peptides

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11078239

Prefusion PIV F immunogens and their use

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11052057

Use of cysteamine and derivatives thereof to suppress tumor metastases

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11026947

ALK2 inhibitors and methods for inhibiting BMP signaling

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10822608

Oligonucleotide analogues targeting human LMNA

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10767184

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10538590

Photosensitizing antibody-fluorophore conjugates

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10351844

Methods and compositions for treating leber congenital amaurosis

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10350306

Methods and compositions for treating genetically linked diseases of the eye

granted patent

US 10300095

AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10227395

Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10188714

Yeast-MUC1 immunotherapeutic compositions and uses thereof

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10143721

Combination product for the prevention of sexually transmitted infections

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted